Rejection

Gerad Taylor Your grant went unscored; the review panel returned the manuscript without review. Your reaction may reveal how well you deal with rejection, and even whether you want to pursue a science career. Still angry? You say the reviewers were, um, less than intelligent? That may not be a constructive reaction, according to studies and experts. A study by ecologists Phillip Cassey of Ecole Normale Superieure in Paris and Tim Blackburn of University of Birmingham, UK, examined failure-to-

Written byJill Adams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Your grant went unscored; the review panel returned the manuscript without review. Your reaction may reveal how well you deal with rejection, and even whether you want to pursue a science career.

Still angry? You say the reviewers were, um, less than intelligent? That may not be a constructive reaction, according to studies and experts. A study by ecologists Phillip Cassey of Ecole Normale Superieure in Paris and Tim Blackburn of University of Birmingham, UK, examined failure-to-publish rates and attitudes of ecologists who had published in leading journals.1

"Who gets rejected? Everyone," they write. On average, 22% of each survey participant's papers were rejected at least once. Views of rejection were found to depend on rejection rate. For example, ecologists with higher rejection rates were more likely to blame poor refereeing or faulty editorial processes than were those with lower rejection rates. Those with the low rates more often viewed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies